Charles Swanton to Neoplasms
This is a "connection" page, showing publications Charles Swanton has written about Neoplasms.
Connection Strength
1.382
-
Consequences of COVID-19 for cancer care - a CRUK perspective. Nat Rev Clin Oncol. 2021 01; 18(1):3-4.
Score: 0.115
-
Cancer Research: The Lessons to Learn from COVID-19. Cancer Discov. 2020 09; 10(9):1263-1266.
Score: 0.112
-
Determinants and clinical implications of chromosomal instability in cancer. Nat Rev Clin Oncol. 2018 03; 15(3):139-150.
Score: 0.094
-
Cancer therapeutics through an evolutionary lens. J R Soc Med. 2018 Jan; 111(1):8-14.
Score: 0.094
-
Cancer Evolution Constrained by the Immune Microenvironment. Cell. 2017 08 24; 170(5):825-827.
Score: 0.091
-
The GENIE Is Out of the Bottle: Landmark Cancer Genomics Dataset Released. Cancer Discov. 2017 08; 7(8):796-798.
Score: 0.091
-
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome. BMC Med. 2017 07 18; 15(1):133.
Score: 0.091
-
Implications of cancer evolution for drug development. Nat Rev Drug Discov. 2017 Jul; 16(7):441-442.
Score: 0.089
-
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell. 2017 02 09; 168(4):613-628.
Score: 0.088
-
Constraints in cancer evolution. Biochem Soc Trans. 2017 02 08; 45(1):1-13.
Score: 0.088
-
The Role of Aneuploidy in Cancer Evolution. Cold Spring Harb Perspect Med. 2017 Jan 03; 7(1).
Score: 0.088
-
Re-Evaluating Clonal Dominance in Cancer Evolution. Trends Cancer. 2016 05; 2(5):263-276.
Score: 0.083
-
Translational implications of tumor heterogeneity. Clin Cancer Res. 2015 Mar 15; 21(6):1258-66.
Score: 0.077
-
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020 08; 21(8):1035-1044.
Score: 0.028
-
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol. 2020 08; 31(8):1065-1074.
Score: 0.028
-
An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or Blood. Methods Mol Biol. 2019; 1884:15-42.
Score: 0.025
-
Reply to J.J. Tao et al. J Clin Oncol. 2018 08 10; 36(23):2451.
Score: 0.024
-
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study. J Clin Oncol. 2018 02 20; 36(6):536-542.
Score: 0.023
-
Evolution and cancer medicine - transformative insights. Nat Rev Clin Oncol. 2017 12; 14(12):709-710.
Score: 0.023
-
Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution. Cold Spring Harb Perspect Med. 2017 Aug 01; 7(8).
Score: 0.023
-
The function and dysfunction of memory CD8+ T cells in tumor immunity. Immunol Rev. 2018 05; 283(1):194-212.
Score: 0.006